在牛皮关节炎频谱中的治疗窗口
Ji-Hyoun Kang1,2, Laura C Coates3
1Division of Rheumatology, Department of Internal Medicine, Chonnam National University Medical School and Hospital, Gwangju, South Korea.
Rheumatology and therapy
|December 27, 2025
概括
早期干预和向治疗,包括生物药物,可以显著改善牛皮关节炎 (PsA) 的结果. 积极的管理和治疗到目标的策略是实现持久缓解和提高PsA患者的生活质量的关键.
科学领域:
- 类风湿病学 类风湿病学
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
背景情况:
- 牛皮关节炎 (PsA) 是一种渐进的炎症状况,通常与牛皮同时发生.
- 早期发现和干预对于改变长期疾病结果至关重要.
- 识别关键的机会窗口可以优化治疗策略.
研究的目的:
- 审查整个疾病谱的牛皮关节炎 (PsA) 治疗策略的发展.
- 突出早期干预和先进疗法的风险分层使用的理由.
- 讨论生物药物和新兴治疗方法在治疗PsA中的作用.
主要方法:
- 关于近期临床试验的文献综述和PsA治疗指南.
- 专注于从早期疾病 (牛皮,非常早期的PsA) 到已建立的PsA的治疗策略.
- 对包括生物药物和新型口服抑制剂在内的向疗法的分析.
主要成果:
- 早期使用向疗法,包括生物药物 (抗TNF,抗IL-17,抗IL-23),可以改善皮肤和关节症状控制和缓解等结果.
- 具有监测和升级的处理到目标策略对于优化结果至关重要.
- 新型口服药物 (例如TYK2抑制剂,IL-23受体对抗剂) 是有前途的,但需要进一步的长期数据.
结论:
- PsA管理正在向积极主动的方法过渡.
- 早期检测,快速获取生物药物和治疗到目标策略对于持久的缓解和改善生活质量至关重要.
- 未来的研究应该专注于定义早期的PsA,预测进展,并整合新的疗法.
相关概念视频
01:29Inflammatory Bowel Disease IV: Pharmacological Management
439
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
439
01:29Therapeutic Drug Monitoring: Affecting Factors
170
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
170
01:16Therapeutic Drug Monitoring: Overview and Classification
264
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
264
01:24T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
01:13Therapeutic Index
6.4K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.4K
01:26Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K